MSCs-Derived Exosomes Attenuate Acute Brain Injury and Inhibit Microglial Inflammation by Reversing CysLT2R-ERK1/2 Mediated Microglia M1 Polarization
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MSCs-Derived Exosomes Attenuate Acute Brain Injury and Inhibit Microglial Inflammation by Reversing CysLT2R-ERK1/2 Mediated Microglia M1 Polarization
Authors
Keywords
-
Journal
NEUROCHEMICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-28
DOI
10.1007/s11064-020-02998-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry
- (2019) Ye Tian et al. Journal of Extracellular Vesicles
- RIPK3/MLKL-Mediated Neuronal Necroptosis Modulates the M1/M2 Polarization of Microglia/Macrophages in the Ischemic Cortex
- (2018) Jiping Yang et al. CEREBRAL CORTEX
- Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses
- (2018) Duo Zhang et al. MOLECULAR THERAPY
- Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia
- (2018) Rosa C. Paolicelli et al. NEUROSCIENCE
- Correction: MiR-21 in Extracellular Vesicles Leads to Neurotoxicity via TLR7 Signaling in SIV Neurological Disease
- (2018) Sowmya V. Yelamanchili et al. PLoS Pathogens
- A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
- (2018) Syed Obaidur Rahman et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Exosomes as novel bio-carriers for gene and drug delivery
- (2017) Xin-Chi Jiang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
- (2017) Paolo Gelosa et al. MEDIATORS OF INFLAMMATION
- Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis
- (2017) Yuxian Song et al. STEM CELLS
- MicroRNA-27a Negatively Modulates the Inflammatory Response in Lipopolysaccharide-Stimulated Microglia by Targeting TLR4 and IRAK4
- (2016) Yan-ni Lv et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
- (2015) Yu Tang et al. MOLECULAR NEUROBIOLOGY
- HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats
- (2015) Q.J. Shi et al. NEUROSCIENCE
- Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis
- (2015) Xiaohong Wang et al. Scientific Reports
- Distinct molecular basis for endothelial differentiation: Gene expression profiles of human mesenchymal stem cells versus umbilical vein endothelial cells
- (2014) Dandan Liu et al. CELLULAR IMMUNOLOGY
- Exosome-Mediated Transfer of miR-133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth
- (2012) Hongqi Xin et al. STEM CELLS
- Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain
- (2011) Xiaoying Zhuang et al. MOLECULAR THERAPY
- Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats
- (2011) C.Z. Zhao et al. NEUROSCIENCE
- Differential Signaling of Cysteinyl Leukotrienes and a Novel Cysteinyl Leukotriene Receptor 2 (CysLT2) Agonist, N-Methyl-Leukotriene C4, in Calcium Reporter and Arrestin Assays
- (2010) D. Yan et al. MOLECULAR PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started